Please login to the form below

Not currently logged in
Email:
Password:

Sanofi appoints general manager UK

Hugo Fry previously served as chief marketing officer at Sanofi Pasteur

Sanofi Hugo FrySanofi has appointed Hugo Fry as the new general manager of its UK and Ireland business.

Fry brings over two decades of commercial, strategic and management experience to the Guildford-based branch, most recently from Sanofi Pasteur where he had been vice president and chief marketing officer since January 2015.

Prior to this, Fry served as global project leader for Lixisenatide at Sanofi's diabetes unit, having moved from TMC Pharma where he served as vice president of medical.

He also brings medical leadership expertise from Boehringer Ingelheim, Linde, Pfizer and the University of Surrey's Clinical Research Centre.
Fry said: “I am honoured to be appointed as general manager for the UK.

“I am proud and motivated to lead our more than 1,800 UK colleagues, who continuously demonstrate their commitment to serving the people whose lives we touch.

“Our ambition in the UK is to be a partner in improving the nation's health. We are dedicated to leveraging the unique diversity of our portfolio and strength of our pipeline toempower people to live life to the fullest."

3rd February 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics